Literature DB >> 17139164

Effect of shikonin on human breast cancer cells proliferation and apoptosis in vitro.

Yue Hou1, Tao Guo, Chunfu Wu, Xiang He, Minghong Zhao.   

Abstract

Shikonin, isolated from the plant Lithospermum erythrorhizon Sieb. Et Zucc, has been reported to induce apoptosis in several tumor cells. However, such effect of shikonin on human breast cancer cells has not been reported. Thus, in the present study, whether shikonin could induce MCF-7 human breast cancer cell apoptosis was investigated. The results showed that shikonin (2.5-80 microM) induced MCF-7 cell death in a time- and dose-dependent manner, as measured by MTT assay. The IC(50) of a 24 h, 48 h and 72 h time course for MCF-7 cells was 7.4+/-0.4, 6.3+/-0.6 and 3.9+/-0.5 microM, respectively. Cellular morphology observation showed that MCF-7 cells underwent marked apoptotic morphological changes upon treatment with 10 microM shikonin compared with the untreated control. Flow cytometric analysis of shikonin-treated MCF-7 cells showed that the ratio of the apoptotic DNA fragmentation increased in a dose-dependent manner. The present study demonstrated for the first time that the cytotoxic effect of shikonin on MCF-7 cells underwent apoptosis process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17139164     DOI: 10.1248/yakushi.126.1383

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  18 in total

1.  In vitro screening of tumoricidal properties of international medicinal herbs: part II.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Phytother Res       Date:  2010-12       Impact factor: 5.878

2.  PKM2 Is Essential for Bladder Cancer Growth and Maintenance.

Authors:  Yong Xia; Xing Wang; Yan Liu; Ellen Shapiro; Herbert Lepor; Moon-Shong Tang; Tung-Tien Sun; Xue-Ru Wu
Journal:  Cancer Res       Date:  2022-02-15       Impact factor: 13.312

3.  Shikonin enhances efficacy of a gene-based cancer vaccine via induction of RANTES.

Authors:  Hui-Ming Chen; Pi-Hsueh Wang; Kandan Aravindaram; Yun-Hsiang Chen; Hsiu-Hui Yu; Wen-Chin Yang; Ning-Sun Yang
Journal:  J Biomed Sci       Date:  2012-04-12       Impact factor: 8.410

4.  Shikonin Induces Apoptosis, Necrosis, and Premature Senescence of Human A549 Lung Cancer Cells through Upregulation of p53 Expression.

Authors:  Yueh-Chiao Yeh; Tsun-Jui Liu; Hui-Chin Lai
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-09       Impact factor: 2.629

5.  Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer.

Authors:  Ravi Thakur; Rachana Trivedi; Namrata Rastogi; Manisha Singh; Durga Prasad Mishra
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

6.  Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells.

Authors:  Wenjuan Li; Joan Liu; Kasey Jackson; Runhua Shi; Yunfeng Zhao
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

7.  Shikonin induces apoptosis in the human gastric cancer cells HGC-27 through mitochondria-mediated pathway.

Authors:  Yue Hou; Jinghua Xu; Xia Liu; Xichun Xia; Ning Li; Xiuli Bi
Journal:  Pharmacogn Mag       Date:  2015 Apr-Jun       Impact factor: 1.085

8.  Effect of β,β-dimethylacrylshikonin on inhibition of human colorectal cancer cell growth in vitro and in vivo.

Authors:  Yingying Fan; Shaoju Jin; Jun He; Zhenjun Shao; Jiao Yan; Ting Feng; Hong Li
Journal:  Int J Mol Sci       Date:  2012-07-23       Impact factor: 6.208

9.  Preparation, cellular uptake and angiogenic suppression of shikonin-containing liposomes in vitro and in vivo.

Authors:  Hongmei Xia; Chengyi Tang; Heng Gui; Xiaoming Wang; Jinliang Qi; Xiuqiang Wang; Yonghua Yang
Journal:  Biosci Rep       Date:  2013-02-01       Impact factor: 3.840

10.  In vitro induction of erythrocyte phosphatidylserine translocation by the natural naphthoquinone shikonin.

Authors:  Adrian Lupescu; Rosi Bissinger; Kashif Jilani; Florian Lang
Journal:  Toxins (Basel)       Date:  2014-05-13       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.